JPRN-UMIN000031161已完成未知
A exploratory study to evaluate the efficacy of the narrow band UVB therapy by Area selection type ultraviolet radiation treatment device in subjects with papuloerythroderma of Ofuji - the narrow band UVB therapy by Area selection type ultraviolet radiation treatment device in subjects with papuloerythroderma of Ofuji
Kobe University Graduate School of Medicine0 个研究点目标入组 10 人开始时间: 2018年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with malignant tumor complications 2.Patient with complication of skin malignancy or previous medical history 3.Patients with high cancer risk 4.Patients diagnosed with eczema secondary erythroderma (senile erythroderma), chronic prurigo, atopic dermatitis, drug eruption, lichen planus, eosinophilia syndrome, cutaneous amyloidosis, cutaneous lymphoma , leukemia 5.Patients undergoing Cyclosporine oral administration, etretinate orally,immunosuppressive therapy treatment 6. patients undergoing oral corticosteroid treatment with 21 mg or more per day in terms of prednisolone 7.Patients whose usage, dose of oral treatment, topical treatment has been changed within 2 weeks 8.Patients taking drugs that cause photosensitivity, patients with outstanding photosensitivity 9.Patients who have received UVB ultraviolet radiation therapy within 3 months 10.Patients who participated in other clinical trials within 4 months 11.patients judged inappropriate
研究者
相似试验
尚未招募
不适用
An exploratory study to evaluate the efficacy of novel enteral nutrition VVT-01 for nasal tube feeding patientsnasal tube feeding patientsJPRN-UMIN000036569Michinoo hospital20
已完成
不适用
An exploratory study to evaluate the efficacy of the single ingestion of milk protein hydrolysate on cerebral activity.JPRN-UMIN000025347Morinaga Milk Industry Co., LTD.36
进行中（未招募）
1 期
The exploratory study of EFE in COVID-19 patientsCOVID-19JPRN-jRCT2031210063Odaguchi Hiroshi156
进行中（未招募）
1 期
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.Chronic spontaneous urticaria and the following skin disorders:1 - Eczema/dermatitis (acute eczema, chronic eczema, contact dermatitis, atopic dermatitis, nummular eczema, autosensitisation dermatitis, dyshidrotic eczema, asteatotic eczema, lichen simplex chronicus).2 - Prurigo (acute prurigo, subacute prurigo, chronic prurigo).3 - Cutaneous pruritus (systemic cutaneous pruritus, local cutaneous pruritus).MedDRA version: 19.0Level: HLTClassification code 10012435Term: Dermatitis and eczemaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10037083Term: PrurigoSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10052568Term: Urticaria chronicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2016-001505-17-ESFAES FARMA, S.A.115
进行中（未招募）
1 期
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.EUCTR2016-001505-17-HUFAES FARMA, S.A.115